Ivím Health Study Featured in Medscape: Are We Prescribing GLP-1s Wrong?
Ivím Health’s individualized GLP-1 care model was recently featured in Medscape in a clinical commentary examining standard prescribing practices for GLP-1 medications. The piece references Ivím Health’s published study of 1,131 patients, which showed 21.8% average total body weight loss over 68 weeks within a comprehensive, individualized care protocol. This compares to 14.9% reported in the landmark STEP 1 trial over the same period. The commentary highlights how frequent patient touchpoints, individualized dosing, and ongoing clinical support are associated with meaningfully better outcomes than a standard prescription-and-follow-up approach.
Read the full article on Medscape
Disclaimer: The information referenced in this article is based on a published observational study. Results may vary. This content is for general informational purposes only and does not constitute medical advice. Please consult a healthcare provider for personalized guidance.
